Drug Insights

The Synapse User's Toolkit: Tips for Searching Propofol

22 March 2024
2 min read

Propofol, an agonist of the GABAA receptor, is a small molecule drug primarily used for anesthesia. Originating from AstraZeneca, propofol gained approval for use in October 1989. Due to its quick onset and short duration of action, propofol has become a popular sedative-hypnotic agent for both induction and maintenance of anesthesia. In addition to its anesthetic properties, propofol has been found to have antiemetic properties and can be used as an adjunct therapy for postoperative nausea and vomiting. While propofol offers therapeutic benefits, it also has a potential for misuse and abuse due to its ability to induce deep sedation or unconsciousness at high doses. Despite its established uses, the precise mechanism of action of propofol is not yet fully understood, and further research is needed to elucidate its pharmacology. Click on the image below to begin the exploration journey of Propofol through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Mabwell's Novel ADC Targets Nectin-4, Shows Promise in Cervical Cancer Treatment
Latest Hotspot
3 min read
Mabwell's Novel ADC Targets Nectin-4, Shows Promise in Cervical Cancer Treatment
22 March 2024
Mabwell's novel antibody-drug conjugate targeting Nectin-4 in cervical cancer shows significant treatment promise according to initial clinical findings.
Read →
What is an Orphan Drug?
"What" Series
2 min read
What is an Orphan Drug?
22 March 2024
An orphan drug is a pharmaceutical product that is developed to treat, diagnose, or prevent rare diseases or conditions.
Read →
Reddy’s Labs introduces Versavo® (bevacizumab) to the UK market
Latest Hotspot
3 min read
Reddy’s Labs introduces Versavo® (bevacizumab) to the UK market
22 March 2024
Dr. Reddy’s Laboratories Ltd., an international enterprise specializing in pharmaceuticals, has officially declared the introduction of its drug Versavo® (bevacizumab) to the UK market.
Read →
Unlock the Power of Synapse: A Guide to Searching Epinephrine
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Epinephrine
22 March 2024
Epinephrine, a minute molecule drug, exerts its action as an adrenergic receptor agonist by targeting the adrenergic receptor, exhibiting an extensive list of active indications.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.